News Posted on September 3, 2024 Aspire Biopharma Inks SPAC Deal At $316M Valuation – Law360 Aspire Biopharma Inks SPAC Deal At $316M Valuation Law360 Source: Aspire Biopharma Inks SPAC Deal At 6M Valuation – Law360 By sf-admin